• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

LeadIQ’s rapid growth snags venture attention as sales software market stays hot

October 1, 2021 by David Barret Leave a Comment

This morning LeadIQ, a startup working in the sales software market, announced that it has closed a $30 million Series B led by Cathay Innovation. Other investors in the transaction include Fresco Capital, Strong Ventures, and Eight Road Ventures.

LeadIQ frames its product from the perspective of missed revenue targets at companies, which it claims impact nearly two-thirds of today’s deals. The startup’s service is designed to save sales staff time by taking on the brunt of data entry work from the sales prospecting process by automating lead capture. The LeadIQ product also includes analytics covering a customer’s prospecting efficiency, which can then be segmented by worker performance and more general breakdowns like industry and company size.

Previously, LeadIQ raised around $12 million, though the company told TechCrunch that it had only spent $6 million of that total, despite reaching eight-figure ARR (the $10 million threshold).

Why raise more capital if it didn’t need the funds? According to CEO and co-founder Mei Siauw, LeadIQ is moving towards supporting account management instead of merely lead management. Building new products is expensive, and thus more capital will help the company staff up for the work.

Why work towards sales account management over simply focusing on leads? According to Siauw, the effort will help sales teams better work with marketing teams, allowing for more complete information sharing and hopefully better sales results. The CEO likened marketing as similar to fishing with a net. Sales, she said, is more akin to hunting fish with a spear. With account-level tooling leading to more complete information sharing, she hopes to give sales teams a better shot at catching more fish, to extend the analogy.

The company has been efficient to date, as noted above. Frugality, however, is only a virtue in startup-land when it is coupled to rapid growth. LeadIQ hits that mark, having grown its annual recurring revenue (ARR) by around 3x in the last year. The company also sports net retention figures of around 125%, and a strong ratio of account size versus customer acquisition costs. Those are the sorts of metrics that SaaS investors covet.

The LeadIQ round is another datapoint in our understanding of the current market for sales-focused software. It appears to be an active sector with fellow sales software service Gongo.io raising rapid-fire rounds in recent quarters including a $250 million investment earlier this year, and a $200 million check in August of 2020. Gong works in what it calls “the revenue intelligence” market when it raised this June.

The sales software market has also seen exits recently including a $575 million deal between ZoomInfo and the smaller Chorus.ai. Chorus had posted rapid revenue growth ahead of its exit, raising north of $100 million before it sold to the larger company.

LeadIQ has around 115 employes, its CEO said, a number that it intends to double in the next 18 months or so. Today those workers hail from 22 countries, making LeadIQ the epitome of the now-standard micro-multinational model that many early-stage startups are pursuing. Notably LeadIQ has two main hubs, one in the United States and one in Singapore. Siauw says that Europe may be nextLe.

Now flush with more funds than ever, let’s see how quickly LeadIQ can expand its revenues in the next year. That next milestone should help us understand both if the company will become an IPO candidate, and how deep its market truly is.

Source Link LeadIQ’s rapid growth snags venture attention as sales software market stays hot

David Barret
David Barret

Related posts:

  1. Indian food delivery firm Zomato’s co-founder exits after 6 years
  2. U.S. Ex-Presidents Bush, Clinton, Obama band together to aid Afghan refugees
  3. BlueBay, Blackrock, Ashmore and UBS exposed to Evergrande -Morningstar
  4. Airbus talking to China’s aviation regulator about A220 certification – exec

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Amazing First Images From World’s Largest Digital Camera Revealed
  • There’s Only One Person In The World With This Blood Type
  • Garden Snails Now Venomous According To Radical Redefinition, And Things Get Surprisingly Sexy
  • “Allokelping”: Hot New Wellness Trend For Critically Endangered Orcas Showcases Impressive Tool Use
  • Beam Of Light Shone All The Way Through A Human Head For The Very First Time
  • “On My Participation In The Atomic Bomb Project”: Einstein’s Powerful Letter Goes Up For Auction For $150,000
  • Watch Friendly Dolphins Help Lead A Lost Humpback Whale Into Deeper Waters
  • World’s Largest Digital Camera Snaps 2,104 New Asteroids And Millions Of Galaxies Within A Few Hours
  • Cat Or Otter? The Jaguarundi Looks Like Both
  • “The Sea Shall Flow To Jackdaw’s Well”: Old English Mermaid Legend Traced Back Centuries
  • The Fungus Blamed For “Tutankhamun’s Curse” Could Make A Potent Anti-Cancer Drug
  • Space Might Be A Byproduct Of Three-Dimensional Time
  • “Jigsaw”-Like Fresco Made Of Thousands Of Fragments Reveals Artistic Traits Not Seen In Roman Britain Before
  • Frequent Nightmares Are A Worrying Sign Of Early Death And Accelerated Aging, Says New Study
  • UK To DNA Test All Newborn Babies In Plan To Predict And Prevent Disease
  • IFLScience We Have Questions: Why Does Snow Sometimes Look Blue?
  • New Nimbus COVID Variant Present In The UK, Infections Could Spread This Summer
  • Scientists Have Finally Measured How Fast Quantum Entanglement Happens
  • Why Earth’s Magnetic Pole Reversals Are So Fascinating
  • World First Artificial Solar Eclipse Created, The “Closest Thing” To HIV Vaccine Gets FDA Approval, And Much More This Week
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version